301015.SZ SHZ
Qingdao Baheal Medical Inc.
1W: -2.8%
1M: +4.6%
3M: +26.6%
YTD: +7.5%
1Y: +2.8%
3Y: +2.9%
¥25.68 ($3.83)
+0.64 (+2.56%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥13.5B ($2.0B)
52W Range18.4-28.77
Volume6,498,400
Avg Volume7,884,789
Beta0.42
Dividend¥0.57
Analyst Ratings
No analyst coverage
Company Info
CEOGang Fu
Employees2,493
SectorHealthcare
IndustryMedical - Distribution
IPO Date2021-06-30
Websitebahealpharma.com
Building 1, No. 88 Tongbai Road
Qingdao, SD 266042
CN
Qingdao, SD 266042
CN
86 53 26675 6688
About Qingdao Baheal Medical Inc.
Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.
Latest News
No recent news
Recent Insider Trades
No insider trades found